首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   31078篇
  免费   2872篇
  国内免费   1290篇
耳鼻咽喉   398篇
儿科学   597篇
妇产科学   573篇
基础医学   3741篇
口腔科学   555篇
临床医学   3299篇
内科学   5096篇
皮肤病学   770篇
神经病学   2110篇
特种医学   1031篇
外国民族医学   13篇
外科学   4051篇
综合类   3956篇
一般理论   19篇
预防医学   1818篇
眼科学   1136篇
药学   2573篇
  12篇
中国医学   1088篇
肿瘤学   2404篇
  2023年   391篇
  2022年   461篇
  2021年   1146篇
  2020年   1034篇
  2019年   966篇
  2018年   1072篇
  2017年   983篇
  2016年   897篇
  2015年   1245篇
  2014年   1575篇
  2013年   1507篇
  2012年   2284篇
  2011年   2317篇
  2010年   1370篇
  2009年   1142篇
  2008年   1679篇
  2007年   1691篇
  2006年   1664篇
  2005年   1671篇
  2004年   1226篇
  2003年   1047篇
  2002年   946篇
  2001年   780篇
  2000年   789篇
  1999年   757篇
  1998年   420篇
  1997年   349篇
  1996年   266篇
  1995年   298篇
  1994年   239篇
  1993年   169篇
  1992年   305篇
  1991年   288篇
  1990年   277篇
  1989年   251篇
  1988年   217篇
  1987年   202篇
  1986年   197篇
  1985年   148篇
  1984年   103篇
  1983年   69篇
  1982年   45篇
  1981年   52篇
  1979年   72篇
  1978年   52篇
  1977年   51篇
  1976年   42篇
  1974年   65篇
  1973年   60篇
  1972年   63篇
排序方式: 共有10000条查询结果,搜索用时 24 毫秒
1.
综述信息化技术在静脉血栓栓塞症护理领域中风险预测、警报接收与上报、抗凝防治管理、医护人员相关继续医学教育、患者疾病预后管理的应用现状,总结其应用阻碍因素,旨在为我国静脉血栓栓塞症护理信息化建设提供参考。  相似文献   
2.
3.
4.
5.
6.
7.
肝细胞癌(HCC)是最常见的恶性肿瘤之一。尽管在早期诊断和个体化治疗方面取得了进展,但经根治性切除等治疗后,HCC患者的临床预后仍不佳,复发率高。因此,在HCC患者中识别准确可靠的预后标志物是必要的。作为一种新的免疫营养生物标志物,控制营养状态(CONUT)评分已被报道用于预测癌症患者的预后。本文将对术前CONUT评分与HCC肝切除术后预后的研究进展进行综述。  相似文献   
8.
9.

Background

Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.

Methods

We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.

Results

In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).

Conclusions

Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials.  相似文献   
10.
Osteosarcoma is the most common primary malignant bone tumor in children and adolescents. This study aimed to explore the effects of long noncoding RNA CAT104 and microRNA-381 (miR-381) on osteosarcoma cell proliferation, migration, invasion, and apoptosis, as well as the underlying potential mechanism. We found that CAT104 was highly expressed in osteosarcoma MG63 and OS-732 cells. Knockdown of CAT104 significantly inhibited OS-732 cell proliferation, migration, and invasion, but promoted cell apoptosis. CAT104 regulated the expression of miR-381, and miR-381 participated in the effects of CAT104 on OS-732 cells. Zinc finger E-box-binding homeobox 1 (ZEB1) was a direct target gene of miR-381, which was involved in the regulatory roles of miR-381 in OS-732 cell proliferation, migration, invasion, and apoptosis, as well as c-Jun N-terminal kinase (JNK) and Wnt/ -catenin pathways. In conclusion, our research verified that suppression of CAT104 exerted significant inhibitory effects on osteosarcoma cell proliferation, migration, and invasion by regulating the expression of miR-381 and downstream ZEB1, as well as JNK and Wnt/ -catenin pathways.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号